Wilmington News Today | 2 Min News | The Daily News Now!
A groundbreaking new pill is lighting up hope for advanced pancreatic cancer patients, slashing death rates and doubling survival time in trials. Targeting the elusive KRAS gene mutation—present in nearly every case—this daily treatment offers the first clear victory over traditional chemo. With FDA fast-tracking and potential clinic access in just months, this breakthrough could reshape cancer research and unlock new therapies for other deadly cancers.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/de4f1aa397ff050b